価格表

在庫・価格 : 2025年10月08日 07時41分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Mouse CCL20/MIP-3 alpha MAb (Clone 114906)
データシート※最新のデータシートでない場合があります
MAB760-500 RSDアールアンドディー システムズ
R&D Systems, Inc.
500 μg ¥259,000 1個 追加

在庫・価格 : 2025年10月08日 07時41分 現在

Anti-Mouse CCL20/MIP-3 alpha MAb (Clone 114906)

  • 商品コード:MAB760-500
  • メーカー:RSD
  • 包装:500μg
  • 価格: ¥259,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Lu L et al. Vγ4 T cell-derived IL-17A is essential for amplification of inflammatory cascades in ischemic brain tissue after stroke. Int Immunopharmacol 2021 Jul;96:107678
Lu L et al
2021/01/01
Species: Mouse, Applications: Neutralization PubMed
2 Kashiwagi S et al. Near-infrared laser adjuvant for influenza vaccine. PLoS ONE 2013;8(12):e82899
Kashiwagi S et al
2013/01/01
Species: Mouse, Applications: IHC PubMed
3 Ma Y et al. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J. Exp. Med. 2011 Mar;208(3):491-503
Ma Y et al
2011/01/01
Species: Mouse, Applications: Neutralization PubMed
4 Klein M et al. Leukocyte attraction by CCL20 and its receptor CCR6 in humans and mice with pneumococcal meningitis. PLoS ONE 2014;9(4):e93057
Klein M et al
2014/01/01
Species: Mouse, Applications: Neutralization PubMed
5 Kawa Y et al. Role of S1P/S1PR3 axis in release of CCL20 from human bronchial epithelial cells. PLoS ONE 2018;13(9):e0203211
Kawa Y et al
2018/01/01
Species: Mouse, Applications: Neutralization PubMed
  • No.: 1
  • 文献情報:
    Lu L et al. Vγ4 T cell-derived IL-17A is essential for amplification of inflammatory cascades in ischemic brain tissue after stroke. Int Immunopharmacol 2021 Jul;96:107678
    Lu L et al
    2021/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Kashiwagi S et al. Near-infrared laser adjuvant for influenza vaccine. PLoS ONE 2013;8(12):e82899
    Kashiwagi S et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Ma Y et al. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J. Exp. Med. 2011 Mar;208(3):491-503
    Ma Y et al
    2011/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Klein M et al. Leukocyte attraction by CCL20 and its receptor CCR6 in humans and mice with pneumococcal meningitis. PLoS ONE 2014;9(4):e93057
    Klein M et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kawa Y et al. Role of S1P/S1PR3 axis in release of CCL20 from human bronchial epithelial cells. PLoS ONE 2018;13(9):e0203211
    Kawa Y et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed